Volastra Therapeutics
Senior Director of Chemistry
Quentis Therapeutics, Inc Aug 2018 - Oct 2019
Director of Chemistry
Bioverativ 2017 - Jul 2018
Principal Scientist Chemistry
Boehringer Ingelheim 2015 - 2017
Senior Principal Scientist
Boehringer Ingelheim 2006 - 2015
Principal Scientist
Education:
Uc Irvine Jan 1, 1999 - 2001
University of California, Berkeley Jan 1, 1994 - 1999
Doctorates, Doctor of Philosophy, Chemistry
Boston College Jan 1, 1990 - 1994
Bachelors, Bachelor of Science, Chemistry
Skills:
Medicinal Chemistry Drug Discovery Drug Design Organic Synthesis Organic Chemistry Lead Optimization Synthetic Chemistry
Derek Cogan - Sandy Hook CT, US Ming-Hong Hao - Ridgefield CT, US Victor Marc Kamhi - Framingham MA, US Craig Andrew Miller - Danbury CT, US Matthew Russell Netherton - Danbury CT, US Alan David Swinamer - Bethel CT, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
Derek Cogan - Sandy Hook CT, US Daniel R. Goldberg - Redding CT, US Ming-Hong Hao - Ridgefield CT, US Zhaoming Xiong - Danbury CT, US Ronald A. Aungst - Clifton Park NY, US Amy L. Davis - Schoharie NY, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
Derek Cogan - Sandy Hook CT, US Daniel R. Goldberg - Redding CT, US Abdelhakim Hammach - Danbury CT, US Matthew Russell Netherton - Danbury CT, US Ronald A. Aungst - Clifton Park NY, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
Derek Cogan - Sandy Hook CT, US Ming-Hong Hao - Ridgefield CT, US Victor Marc Kamhi - Framingham MA, US Craig Andrew Miller - Ridgefield CT, US Matthew Russell Netherton - Danbury CT, US Alan David Swinamer - Bethel CT, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
Derek A. Cogan - Sandy Hook CT, US Ming-Hong Hao - Ridgefield CT, US Kevin Chungeng Qian - New Milford CT, US Alan David Swinamer - Southbury CT, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
A61K 31/497 C07D 405/00
US Classification:
51425213, 514326, 514340, 546208, 5462684, 544366
Abstract:
Disclosed are compounds of formula (I)Where Ar, X, R, R, Rand Rare defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
Derek Cogan - Sandy Hook CT, US Daniel R. Goldberg - Redding CT, US Ming-Hong Hao - Ridgefield CT, US Zhaoming Xiong - Danbury CT, US Ronald A. Aungst - Clifton Park NY, US Amy L. Davis - Schoharie NY, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT